2025-12-29 - Analysis Report
Here's a comprehensive analysis of Lam Research (LRCX) based on the provided data:

**0) Simple Numbers and Analysis:**

**1) Return Rate Comparison (LRCX vs. VOO):**

*   **LRCX:** 270.69% Cumulative Return
*   **VOO (S&P 500):** 103.21% Cumulative Return
*   **Divergence:** 157.7 (Relative Divergence: 100.0)

**Analysis:** Lam Research has significantly outperformed the S&P 500, with a cumulative return far exceeding VOO.  The divergence of 157.7 indicates a substantial difference in performance. The relative divergence of 100.0 means the current divergence is at the maximum end of its historical range.

**Company Overview:** Lam Research Corp provides wafer fabrication equipment and services to the semiconductor industry.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha | Beta | Cap(B) |
|------------|--------|-------|-------|------|--------|
| 2015-2017  | 84.0%  | 67.8% | 56.0% | 0.0  | 23.2   |
| 2016-2018  | 18.0%  | 68.1% | 3.0%  | 0.1  | 17.2   |
| 2017-2019  | 53.0%  | 82.9% | 31.0% | 1.2  | 36.9   |
| 2018-2020  | 66.0%  | 82.9% | 42.0% | 1.1  | 59.5   |
| 2019-2021  | 119.0% | 82.9% | 73.0% | 1.0  | 90.7   |
| 2020-2022  | -10.0% | 79.2% | -9.0% | 0.9  | 53.0   |
| 2021-2023  | -13.0% | 80.4% | -15.0% | 1.0  | 98.8   |
| 2022-2024  | -52.0% | 80.4% | -72.0% | 1.0  | 91.1   |
| 2023-2025  | 182.0% | 80.4% | 114.0% | 0.9  | 224.6  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate fluctuates significantly, indicating periods of strong growth followed by declines, and a recent surge.
*   **MDD:** The Maximum Drawdown is consistently high, highlighting the stock's volatility.  This means investors should be prepared for substantial potential losses.
*   **Alpha:** A high positive Alpha (especially in recent years except 2020-2024) suggests LRCX has generated returns beyond what would be expected based on market risk alone, indicating good stock picking ability. Negative alpha indicates underperformance relative to the benchmark.
*   **Beta:**  Beta hovers around 1, suggesting LRCX's price moves roughly in line with the overall market.
*   **Cap(B):** Market capitalization has significantly increased, especially in the most recent period (2023-2025).

**2) Recent Stock Price Fluctuations:**

*   **Close:** 178.07
*   **Previous Close:** 177.33
*   **Change:** 0.42
*   **5-day SMA:** 175.62
*   **20-day SMA:** 164.92
*   **60-day SMA:** 154.97

**Analysis:** The stock price is currently above all three Simple Moving Averages (SMA), which suggests an upward trend. The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA, further reinforcing this bullish signal. The small change from the previous close indicates relative price stability in the last day.

**3) RSI, PPO, Divergence, and Expected Return:**

*   **MRI (Market Risk Indicator):** 1.0 (High Investment Recommended)
*   **RSI:** 67.74
*   **PPO:** 0.76
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent (20 days) Relative Divergence Change:** 9.1 (+) 단기상승 (Short-term rise)
*   **Expected Return (%):** 14.2%

**Analysis:**

*   **MRI:** A score of 1.0 signals that the model recommends high investment in the current market conditions.
*   **RSI:** An RSI of 67.74 indicates that the stock is approaching overbought conditions but isn't there yet.  A value above 70 is typically considered overbought.
*   **PPO:** A positive PPO suggests that the short-term moving average is above the long-term moving average, indicating an upward trend.
*   **Hybrid Signal:** The signal suggests buying, reflecting the model's positive outlook.
*   **Relative Divergence Change:** An increase in relative divergence suggests positive momentum in the short term.
*   **Expected Return:** The 14.2% expected return (over 2 years) is quite attractive and exceeds the expected return of S&P 500.

**4) Recent News & Significant Events (Yahoo Finance):**

*   Multiple articles highlight LRCX holding near record highs and analyst optimism.
*   B. Riley names Lam Research a Top Memory Recovery Play.
*   Cwm LLC and Matthews International Capital Management LLC purchased shares, indicating institutional confidence.
*   Citi raises its price target on Lam Research.

**Analysis:** The news flow is predominantly positive, with analysts raising price targets and institutions increasing their positions. This suggests strong market confidence in LRCX's future performance.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.79)
*   **Target Price (avg/high/low):** 166.97 / 210.00 / 84.00

**Analysis:** The analyst consensus is a "Buy" with an average target price of $166.97. This is below the current price of $178.07, suggesting that analysts, on average, believe the stock might be slightly overvalued. However, some analysts have targets as high as $210, indicating a potential upside.

**5) Recent Earnings Analysis:**

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2025-10-24 | 1.24  | 5.32 B$    |
| 2025-04-25 | 1.04  | 4.72 B$    |
| 2025-01-31 | 0.93  | 4.38 B$    |
| 2024-10-28 | 0.86  | 4.17 B$    |
| 2025-10-24 | 0.86  | 4.17 B$    |

**Analysis:** Both EPS and revenue have shown a consistent upward trend over the past few quarters, indicating strong financial performance and growth for the company.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $5.32B     | 50.43%        |
| 2025-06-30   | $5.17B     | 50.08%        |
| 2025-03-31   | $4.72B     | 49.02%        |
| 2024-12-31   | $4.38B     | 47.37%        |
| 2024-09-30   | $4.17B     | 48.05%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-09-30   | $10.19B    | 15.39%   |
| 2025-06-30   | $9.86B     | 17.44%   |
| 2025-03-31   | $9.51B     | 13.99%   |
| 2024-12-31   | $8.81B     | 13.52%   |
| 2024-09-30   | $8.47B     | 13.18%   |

**Analysis:**

*   **Revenue and Profit Margin:** Revenue has been consistently increasing, with a corresponding rise in profit margins. This indicates improved efficiency and profitability.
*   **Equity and ROE:** Equity has also grown steadily, and ROE (Return on Equity) remains strong, suggesting efficient use of shareholder equity to generate profits.

**7) Comprehensive Analysis (Summary):**

Lam Research (LRCX) presents a mixed but generally positive picture:

*   **Strong Performance:** LRCX has significantly outperformed the S&P 500 over the longer term.
*   **Volatile History:** Historical data reveals significant volatility (high MDD), so investors should be prepared for potential downturns.
*   **Positive Momentum:** Recent technical indicators (SMA alignment, positive PPO, increasing relative divergence change) suggest continued upward momentum.
*   **Positive News & Sentiment:** Recent news and analyst ratings are generally positive, indicating market confidence. Institutional ownership is also increasing.
*   **Solid Financials:** Consistent revenue and profit growth, coupled with a strong ROE, demonstrate financial health.
*   **Slight Overvaluation Concern:** The average analyst target price is slightly below the current price, suggesting potential for a mild correction or slowing of growth.
*   **High Investment Recommendation:** The MRI indicator signals a high investment recommendation, further enhancing the investment value for now.

**Overall Recommendation:**

Based on the data, LRCX appears to be a fundamentally strong company with significant growth potential. While the stock may be slightly overvalued in the short term, the positive trends and strong financials suggest continued growth in the long term. Investors should be aware of the inherent volatility associated with the stock and manage their risk accordingly. The current MRI score suggests a favorable investment environment, but it's crucial to stay informed about future market dynamics and adapt strategies as needed.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.